Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Eli Lilly and Company, 3 years.
Eli Lilly and Company
Director
International Flavors & Fragrances Inc.
Director · Chief Executive Officer
Chief executive roles
Since February 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Eli Lilly and Company | Grant or award | +8 | $1,183.16 | $9,917 |
| Jul 20, 2026 | Eli Lilly and Company | Grant or award | +9 | $1,146.90 | $9,917 |
| Jun 15, 2026 | Eli Lilly and Company | Grant or award | +9 | $1,129.35 | $9,916 |
| May 18, 2026 | Eli Lilly and Company | Grant or award | +10 | $988.09 | $9,920 |
| May 1, 2026 | International Flavors & Fragrances Inc. | Option exercise | +15,875 | — | — |
| May 1, 2026 | International Flavors & Fragrances Inc. | Shares withheld for tax | −7,763 | $70.81 | $549,698 |
| Apr 20, 2026 | Eli Lilly and Company | Grant or award | +11 | $919.90 | $9,917 |
| Apr 1, 2026 | International Flavors & Fragrances Inc. | Option exercise | +18,769 | — | — |
| Apr 1, 2026 | International Flavors & Fragrances Inc. | Shares withheld for tax | −8,835 | $72.57 | $641,156 |
| Mar 16, 2026 | Eli Lilly and Company | Grant or award | +10 | $989.12 | $9,921 |
| Mar 13, 2026 | International Flavors & Fragrances Inc. | Open-market purchase | +13,360 | $69.85 | $933,196 |
| Mar 12, 2026 | International Flavors & Fragrances Inc. | Open-market purchase | +900 | $68.87 | $61,983 |
| Feb 17, 2026 | Eli Lilly and Company | Grant or award | +10 | $1,036.05 | $9,915 |
| Jan 20, 2026 | Eli Lilly and Company | Grant or award | +10 | $1,041.29 | $9,913 |
| Dec 15, 2025 | Eli Lilly and Company | Grant or award | +9 | $1,062.19 | $9,921 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.